TrialThe Lancet. Oncology2020

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.

David S Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.